fda-decisionpeptides-regulationresearch-compliance
FDA's April 15 Decision That Changed the Peptide Landscape
The FDA's April 15 ruling alters regulatory oversight of peptides used in research and commerce, with immediate implications for sourcing, compliance, and lab risk management.
April 20, 2026
